Actis Oncology clinical programs

What experts have said about Actis Oncology clinical programs

1 statement · 1 neutral

1. Oleg NodelmanNeutralJun 12, 2026· All-In with Chamath, Jason, Sacks & Friedberg

   Actis expects initial data from its Nectin4 and B7H3 programs in 2027

   “publicly guided to initial clinical data in both of these lead programs in 2027”

   Listen at 27:51

   Open the episode · All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.